Saj Razvi is the director of education at the Psychedelic Somatic Institute. He is a psychotherapist and former clinical researcher in the MAPS phase 2 trials of MDMA-assisted psychotherapy. He is also one of the primary developers of Psychedelic Somatic Interactional Psychotherapy (PSIP) a groundbreaking therapeutic modality that addresses mental health issues at the root cause level. His primary work is in training clinicians to provide legal and effective psychedelic therapy in their private practices. In this episode, we speak about psychedelic psychotherapy, the importance of developing a strong somatic pathway, the healing potential of cannabis & ketamine, and the pitfalls psychedelic healers can fall into.